Overview

Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy

Status:
Unknown status

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

Summary

The primary objective of the study is to increase by 15% the complete macroscopic resection rate of predominantly liver metastases from metastatic colorectal cancer through combining systemic cetuximab and hepatic artery infusion of three-drug chemotherapy (irinotecan, oxaliplatin and 5-fluorouracil).

Phase:

Phase 2

Details

Lead Sponsor:

Association pour la Recherche sur le Temps Biologique et la Chronothérapie

Collaborators:

CRESGE
Gustave Roussy, Cancer Campus, Grand Paris
Merck Serono International SA
Pfizer

Treatments:

Cetuximab
Fluorouracil
Irinotecan
Oxaliplatin